| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 3 | +1,403,436 | 74% | $10.97 | +$15,402,661 |
| Sells | 7 | -500,230 | 26% | $20.97 | -$10,489,727 |
| Net | -4 | +903,206 | 47% | +$4,912,934 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. | 10%+ Owner | $345,672,360 | +$14,999,996 | +4.5% | 18 Feb 2025 |
| TERRY J. ROSEN | Chief Executive Officer, Director | $56,037,974 | -$1,002,494 | -1.8% | 30 Dec 2025 |
| Juan C. Jaen | President | $32,053,302 | -$5,628,460 | -15% | 16 Dec 2025 |
| YASUNORI KANEKO | Director | $7,732,309 | +$201,200 | +2.7% | 10 Jun 2025 |
| Jennifer Jarrett | Chief Operating Officer | $4,376,238 | -$2,171,347 | -33% | 16 Dec 2025 |
| Carolyn Tang | General Counsel | $2,764,043 | -$318,496 | -10% | 16 Dec 2025 |
| Robert Goeltz II | Chief Financial Officer | $1,588,063 | -$656,925 | -29% | 31 Dec 2025 |
| Richard Markus | Chief Medical Officer | $1,454,704 | -$210,144 | -13% | 16 Dec 2025 |
| Dimitry SA Nuyten | Chief Medical Officer | $1,407,289 | 15 Dec 2024 | ||
| KATHRYN E. FALBERG | Director | $1,386,132 | 10 Jun 2025 | ||
| David L. Lacey | Director | $576,130 | 10 Jun 2025 | ||
| Antoni Ribas | Director | $423,888 | 10 Jun 2025 | ||
| William Grossman | Chief Medical Officer | $414,460 | 16 Jun 2021 | ||
| Alexander Azoy | Chief Accounting Officer | $412,236 | -$300,395 | -42% | 16 Dec 2025 |
| ANDREW J. PERLMAN | Director | $346,115 | 10 Jun 2025 | ||
| Patrick Machado | Director | $313,432 | 10 Jun 2025 | ||
| Nicole Lambert | Director | $302,876 | 10 Jun 2025 | ||
| Dietmar Berger | Director | $0 | 06 Feb 2025 | ||
| Johanna Mercier | Director | $0 | 29 Jan 2024 | ||
| Linda Slanec Higgins | Director | 10 Aug 2021 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|